Outsourcing Pharma

APRIL 23, 2024

At CPhI North America, Quotient Sciences is looking forward to reconnecting with its customers and giving them a preview of how we are looking to expand Translational Pharmaceutics further within the US.

70

70

Pharmafile

APRIL 11, 2024

Vertex Pharmaceuticals and Alpine Immune Sciences have announced that they have entered into a definitive agreement under which Vertex will acquire Alpine for $65 per share, totaling an approximate $4.9bn. Alpine’s lead […] The post Vertex to acquire Alpine Immune Sciences for $4.9bn appeared first on Pharmafile.

Immunization 59

Immunization 59

pharmaphorum

OCTOBER 17, 2023

In this latest instalment of the pharmaphorum podcast, web editor Nicole Raleigh speaks with life sciences advisor Randall Hein, CEO of Heinsight LLC, and health sciences marketing expert Krystle Buntemeyer, CEO of SCORR Marketing, about the trends and changes for health sciences marketing over the past few years.

112

112

Pharmaceutical Technology

APRIL 22, 2024

GS-6212 is under clinical development by Gilead Sciences and currently in Phase I for Human Immunodeficiency Virus (HIV) Infections (AIDS).

98

98

European Pharmaceutical Review

MARCH 12, 2024

In the pharmaceutical/life sciences industries, maintaining data integrity is crucial given its role in making critical decisions that shape outcomes from drug development to human health. Ensuring data integrity in the life science industry is crucial for regulatory compliance. What are three current key trends in data integrity?

Documentation 90

Documentation Data Entry Communication Compounding 90

ISPE

SEPTEMBER 28, 2023

Navigating Life Sciences Construction in California Trudy Patterson Thu, 09/28/2023 - 11:40 iSpeak Blog iSpeak Navigating Life Sciences Construction in California Gul Dusi 28 September 2023 Few industries have as deep a footprint in California, USA as life sciences. billion a year. billion a year. billion in 2019 to $17.3

Hospitals 98

Hospitals Documentation Pharmaceutical Companies Pharmaceutical Companies 98

Outsourcing Pharma

APRIL 24, 2024

From a child's chemistry set given to her by her grandfather to watching Open University maths programs, Karen Ooms seemed destined for a career in science.

95

95

Outsourcing Pharma

APRIL 16, 2024

Bios Health Group, a leading strategic and investment partner for life science companies and investors, has officially introduced the Bios Innovation Circle.

71

71

pharmaphorum

MARCH 18, 2024

Discover the top 7 challenges faced by pharmaceutical and life sciences companies in achieving patient-centricity and engaging healthcare professionals (HCPs). Explore strategies to overcome these obstacles for successful outreach efforts.

106

106

pharmaphorum

JANUARY 25, 2024

Discover the role of GenAI in life sciences in 2024. Explore how artificial intelligence and machine learning techniques like GenAI are revolutionising drug development, diagnostics, and research. Learn how industry leaders, including Google, are leveraging GenAI to advance healthcare and enhance patient outcomes.

103

103

pharmaphorum

JANUARY 10, 2024

Explore the latest trends and projections in life sciences real estate, including the impact of digital health, the evolving needs of laboratory facilities, and the future of real estate in this sector. Stay ahead of the curve with insights into the industry's future.

103

103

European Pharmaceutical Review

OCTOBER 10, 2023

Schneider Electric, a leader in digital transformation, energy management and automation, has announced the speaker lineup for its exclusive event, Life Sciences Innovation Day – Accelerating Digital Transformation Ambition. Registration begins at 9:00am. Event concludes at 4:30pm.

101

101

pharmaphorum

NOVEMBER 16, 2023

Life sciences inspections and investigations Mike.Hammerton Thu, 16/11/2023 - 10:23 Bookmark this

104

104

STAT

FEBRUARY 1, 2023

A recent study and accompanying news story in the preeminent journal Nature provocatively concludes that disruptive innovation in science has dramatically and mysteriously declined 90% since 1945. The study has prompted a wave of news coverage and tweets decrying the apparent languishing of modern science.

142

142

pharmaphorum

MARCH 5, 2024

Explore how innovation is shaping the future of life sciences through digital transformation and AI. Learn how incorporating cutting-edge technologies can drive success in the industry.

77

77

STAT

NOVEMBER 1, 2023

Biotech and life sciences investors continue to draw in new funds even as the biotech stock indexes reach new lows. On Wednesday, VC firm Bioluminescence Ventures launched with $477 million to invest in biotech startups.

Pharmaceutical Companies 128

Pharmaceutical Companies Pharmaceutical Companies 128

STAT

JUNE 6, 2023

Freshly minted life science Ph.D. graduates who have started families or have big loans, or are Black or female, say they plan to pursue postdoc positions at lower rates than their peers, according to a STAT analysis that includes previously unreported data from the National Center for Science and Engineering Statistics.

121

121

Pharmaceutical Technology

APRIL 25, 2024

The first episode in Sterling's podcast series on digital dealmaking in life sciences puts a spotlight on corporate culture

52

52

pharmaphorum

FEBRUARY 29, 2024

Explore the impact of the Inflation Reduction Act (IRA) on drug prices and negotiations within the life sciences industry, as it stands on the threshold of change. Gain insights into the potential outcomes and implications of this legislation.

92

92

Pharmaceutical Technology

FEBRUARY 7, 2024

Gilead Sciences has announced a 22.9% increase in net income of $5.61bn for FY23 as against $4.56bn in FY22.

98

98

Pharma Mirror

APRIL 17, 2024

As an authority in radiation oncology, Dr. Khuntia joining the board of directors validates BNCT and the work TAE Life Sciences is doing to make it a mainstay of modern cancer care IRVINE, Calif.- FASTRO, to its esteemed Board of Directors.

52

52

STAT

OCTOBER 17, 2023

The Food and Drug Administration should halt Cassava Sciences’ ongoing clinical trials in Alzheimer’s disease. That, and other thoughts on the fallout from the City University of New York investigation that raised serious doubts about the science underpinning the company’s experimental drug simufilam.

FDA 128

FDA 128

pharmaphorum

SEPTEMBER 15, 2023

Driving data & analytics transformation in life sciences Mike.Hammerton Fri, 15/09/2023 - 08:00 Bookmark this

114

114

STAT

MARCH 4, 2024

Governor Maura Healey’s long-awaited plan to double down on state funding for the biotech and medical technology sector came into focus Thursday with the announcement she’ll seek $1 billion over the next decade to reauthorize the state’s 16-year-old life sciences initiative.

89

89

pharmaphorum

DECEMBER 8, 2023

Life sciences industry predictions 2024: Curavit Mike.Hammerton Fri, 08/12/2023 - 14:15 Bookmark this

93

93

Drug Store News

SEPTEMBER 13, 2023

Lucas Morgan, partner at Frier Levitt’s Healthcare and Life Sciences Litigation Department, shares important information pharmacists need to know to protect their businesses.

118

118

STAT

OCTOBER 19, 2023

Their philanthropic funding group, the Chan Zuckerberg Initiative, is committed to investing in an array of fields, including science, education, housing insecurity, and expanding access to startup capital to entrepreneurs of color.

Compounding 133

Compounding 133

European Pharmaceutical Review

MAY 26, 2023

The UK Chancellor has announced a £650 million life sciences growth package (Life Sci for Growth) to help deliver the Science and Technology framework through reforming regulation, boosting investment and driving up talent and skills.

Packaging 102

Packaging Vaccines 102

Drug Store News

AUGUST 15, 2023

Thomas Swalla, CEO of Dotmatics, takes a look at how the power of data science can help aid in R&D innovations.

95

95

pharmaphorum

DECEMBER 8, 2022

Life Sciences Council. Do you know about the Life Sciences Council (LSC)? The LSC has a website on Gov.uk, but the page says Life Sciences Council. A post from the director of health and life sciences at Innovate UK, Richard J Hebdon, also bigged up the news before the Council met about four health missions.

Documentation 91

Documentation 91

NF2 BioSolutions

JUNE 5, 2023

It’s NF2 science, but summarised! Visit the previous blog post in this series: Science Summarised: Potential New Drugs for Hearing Loss This blog was written by NF2 BioSolutions PhD student Grace Gregory. This blog has been created as a way to share stories, ideas, positivity and even sprinkle in some science.

Immunization 98

Immunization 98

Fierce Healthcare

SEPTEMBER 28, 2023

At-home diagnostics startup Viome Life Sciences has launched a new test to help detect oral and throat cancers. | The test relies on Viome’s proprietary RNA sequencing technology and AI to measure gene expression of the oral microbiome and human cells in each patient’s saliva, which are used to identify early biomarkers associated with oral and throat (..)

117

117

Pharmaceutical Technology

SEPTEMBER 8, 2023

In this issue: Digital jobs in UK life sciences, generative AI changes drug discovery, and how robotics is impacting gene therapy manufacturing.

97

97

STAT

FEBRUARY 12, 2024

And while the occasion is most closely associated with ads for beer, cars, and soft drinks, pharma giant Pfizer dished out millions of dollars for its own message: “Here’s to science.”

Hospitals 139

Hospitals 139

Pharma Mirror

JANUARY 19, 2024

As we step into 2024, the global life science industry finds itself at a crossroads, facing plenty of challenges alongside an abundance of exciting opportunities. The pharmaceutical and contract outsourcing space has shifted, with new trends emerging that will shape the future of this rapidly changing industry.

Vaccines 52

Vaccines 52

Pharmafile

JANUARY 5, 2024

Rhythm Pharmaceuticals and LG Chem Life Sciences have announced that they have entered into a global licensing agreement for LB54640, an investigational oral small molecule melanocortin-4 receptor (MC4R) agonist which is currently in phase 2 clinical trials.

64

64

Outsourcing Pharma

APRIL 8, 2024

In an exclusive interview with Dr Vanessa Zann, (pictured below) executive drug development consultant at Quotient Sciences, OSP delved into the forefront of pharmaceutical research and development.

59

59